References
- Larsson R., Jonsson B., Csoka K., Kristensen J., Nilsson K., Nygren P. Selective cytotoxicity activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia. Eur. J. Pharmacol. 1992; 228: 237–240
- Chikkappa G., Pasquale D., Phillips P. G., Mangan K., Tsan M. F. Cyclosporin-A for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemia. Am. J. Hematol. 1987; 26: 179–189
- Christen R., Morant R., Fehr J. Cyclosporin-A therapy of pure red cell aplasia in a patient with B-cell chronic lymphocytic leukaemia. Eur. J. Haematol. 1989; 42: 303–307
- Chikkappa G., Pasquale D., Zarrabi M. H., Weiler R. J., Divakara M., Tsan M. F. Cyclosporine and Prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia. Am. J. Hematol. 1992; 41: 5–12
- Platsoucas C., Galinski M., Kemplin S., Reich L., Clarkson B., Good R. Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. J. Immunol. 1982; 129: 2305–2312
- Chiorazzi N., Fu S. M., Montazeri G., Kunkel H. G., Rai K., Gee T. T cell helper defects in patients with chronic lymphocytic leukemia. J. Immunol. 1979; 122: 1087–1090
- Antica M., Kusic B., Spaventi R., Branimir J., Vitale B. Functional differences of T cells in B-chronic lymphocytic leukemia. Leuk, and Lymph. 1993; 9: 133–140
- Di Raimondo F., Giustolisi R., Cacciola E., O'Brien S., Kantarjian H., Robertson L. E., Keating M. J. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk. and Lymph. 1993; 11: 63–68
- Mangan K., Chikkappa G., Farley P. C. T gamma cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. J. Clin. Invest. 1982; 70: 1148–1156
- Tura S., Finelli C., Bandini G., Gobbi M. Cyclosporin A in the treatment of CLL associated PRCA and bone marrow hypoplasia. Nouvelle Revue Francaise Hematologie 1988; 30: 479–481
- Freedman A. S., Nadler L. M. Immunologic markers in B-cell chronic lymphocytic leukemia. Chronic Lymphocytic Leukemia, B. D. Cheson. Marcel Decker, New York 1993; 13
- Kipps T. J., Carson D. A. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 1993; 81: 2475–2487
- Kipps T. J., Rassenti L. Z., Duffy S., Johnson T., Kobayashi R., Carson D. A. Immunoglobulin V gene expression in CD5 B-cell malignancies. Ann. New York Acad. Sci. 1992; 651: 373–383
- Inghirami G., Foitl D., Sabichi A., Zhu B. Y., Knowles D. M. Autoantibody-associated cross-reactive idiotype-bearing human B lymphocytes: distribution and characterization, including Ig VH gene and CD 5 antigen expression. Blood 1991; 78: 1503–1515
- Sthoeger Z. M., Wakai M., Tse D. B., Vinciguerra V. P., Allen S. L., Budman D. R., Lichtman S. M., Schulman P., Weiselberg L. R., Chiorazzi N. Production of autoantibodies by CD 5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J. Exper. Med. 1989; 169: 255–268
- Shirai T., Okada T., Hirose S. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia. Ann. New York Acad. Sci. 1992; 651: 509–526
- Borche L., Lim A. N., Binet J. L., Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural antibodies. Blood 1990; 75: 562–569
- Sthoeger Z. M., Sthoeger D., Shtalrid M., Sigler E., Geltner D., Berrebi A. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia. Am. J. Hematol. 1993; 43: 259–264